Avandia is risky, but …
Though two of its own scientists urged the Food & Drug Administration to take the diabetes drug Avandia off the market because it sharply raises the risk of heart failure, an FDA panel on Monday decided to continue to allow it to be sold.
Critics complain it’s more evidence the federal regulatory agency is in the pocket of big drug companies. Here’s the latest.